Scilex Holding SCLX
NASDAQ SCLX
$4.06 -0.34 (-7.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Selling, General & Administrative (2022 - 2026)

Updated

Scilex Holding (SCLX) posted Selling, General & Administrative of $27.96 million for Q2 2026, up 40.9% from $19.84 million a year earlier but down 9.9% from the prior quarter.

Analysis

Scilex Holding (SCLX) Selling, General & Administrative (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Scilex Holding was $277.98 million, up 145.9% year-over-year; for FY2025, it was $266.88 million, up 124.2% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 44.1% (FY2020 to FY2025).
  • In prior years, Scilex Holding's Selling, General & Administrative was $119.02 million in FY2024 (-0.5%), $119.64 million in FY2023 (+84.4%), $64.9 million in FY2022 (+28.3%) and $50.58 million in FY2021 (+17.7%).
  • Quarterly Selling, General & Administrative has run from a low of $10.91 million in Q1 2022 to a high of $188.82 million in Q3 2025 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 71.5%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2025, with growth of 535.0%; the weakest was Q3 2024, with a decline of 26.5%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $31.03 million (Q1 2026), $30.16 million (Q4 2025) and $188.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Scilex Holding 31.02 Mn 19.00 Mn 3.97 Mn 27.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.96 Mn
Mar 31, 2026 31.03 Mn
Dec 31, 2025 30.16 Mn
Sep 30, 2025 188.82 Mn
Jun 30, 2025 19.84 Mn
Mar 31, 2025 28.06 Mn
Dec 31, 2024 35.41 Mn
Sep 30, 2024 29.73 Mn
Jun 30, 2024 24.60 Mn
Mar 31, 2024 29.28 Mn
Dec 31, 2023 23.52 Mn
Sep 30, 2023 40.43 Mn
Jun 30, 2023 26.99 Mn
Mar 31, 2023 28.70 Mn
Dec 31, 2022 23.52 Mn
Sep 30, 2022 16.12 Mn
Jun 30, 2022 14.34 Mn
Mar 31, 2022 10.91 Mn
API Access

Scilex Holding Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SCLX&period=max&api_key=YOUR_API_KEY